Cyclacel Pharmaceuticals, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Cyclacel Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q3 2024.
  • Cyclacel Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $10K, a 93.1% decline year-over-year.
  • Cyclacel Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$293K, a 466% decline year-over-year.
  • Cyclacel Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was -$98K, a 106% decline from 2022.
  • Cyclacel Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $1.74M, a 753% increase from 2021.
  • Cyclacel Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was $204K, a 78.6% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$293K $10K -$135K -93.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$158K -$25K +$80K +76.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$238K $55K -$140K -71.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$98K -$333K -$178K -115% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $80K $145K -$212K -59.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $292K -$105K -$331K -146% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $623K $195K -$1.12M -85.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $1.74M -$155K -$197K -469% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $1.94M $357K +$344K +2646% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-29
Q2 2022 $1.59M $226K +$217K +2411% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $1.38M $1.31M +$1.17M +838% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $204K $42K +$56K Oct 1, 2021 Dec 31, 2021 10-K/A 2023-11-29
Q3 2021 $148K $13K -$22K -62.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $170K $9K -$11K -55% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $181K $140K -$774K -84.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $955K -$14K -$55K -134% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 $1.01M $35K -$139K -79.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $1.15M $20K -$227K -91.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $1.38M $914K +$820K +872% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $556K $41K -$54K -56.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 $610K $174K +$88K +102% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $522K $247K +$136K +123% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $386K $94K -$537K -85.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 $923K $95K -$31K -24.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 $954K $86K +$50K +139% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $904K $111K +$77K +226% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 $827K $631K -$201K -24.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 $1.03M $126K +$206K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-28
Q3 2017 $822K $36K -$41K -53.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $863K $34K -$135K -79.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $998K $832K +$622K +296% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 $376K -$80K -$69K -627% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-30
Q3 2016 $445K $77K -$130K -62.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 $575K $169K +$304K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 $271K $210K +$587K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$316K -$11K +$114K +91.2% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$430K $207K +$198K +2200% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$628K -$135K -$75K -125% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$553K -$377K -$341K -947% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$212K -$125K -$73K -140% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-29
Q3 2014 -$139K $9K -$40K -81.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$99K -$60K -$5.46M -101% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 $5.36M -$36K -$731K -105% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q4 2013 $6.09M -$52K +$361K +87.4% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 $5.73M $49K +$99K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 $5.63M $5.4M +$5.1M +1665% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 $538K $695K +$542K +354% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q4 2012 -$4K -$413K -$376K -1016% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-26
Q3 2012 $372K -$50K -$527K -110% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 $899K $306K +$187K +157% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $712K $153K +$132K +629% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-13
Q4 2011 $580K -$37K Oct 1, 2011 Dec 31, 2011 10-K 2014-03-26
Q3 2011 $477K +$429K +894% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-16
Q2 2011 $119K -$104K -46.6% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 $21K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 $48K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 $223K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.